Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neurología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Terminado
Fase 3
ClinicalTrials.gov
A Multicenter, International, Randomized, Active Comparator-controlled, Double-blind, Double-dummy, Parallel-group, 2-arm, Phase 3 Study to Compare the Efficacy and Safety of the Oral FXIa Inhibitor Asundexian (BAY 2433334) With Apixaban for the Prevention of Stroke or Systemic Embolism in Male and Female Participants Aged 18 Years and Older With Atrial Fibrillation at Risk for Stroke
INTERVENTIONAL
Inicio: 5 de dic de 2022
ID: NCT05643573
Completado
Fase 4
ClinicalTrials.gov
Phase IV Open Label Uncontrolled Trial of the Dual Blockade of the Renin Angiotensin System With Enalapril Plus Valsartan Combined With Oral Methylprednisolone for the Treatment of Proteinuria in IGA Nephropathy
INTERVENTIONAL
Inicio: 1 de ene de 1996
ID: NCT00367562
Completado
Fase 3
ClinicalTrials.gov
An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
INTERVENTIONAL
Inicio: 1 de ago de 2009
ID: NCT00930553
Desconocido
ClinicalTrials.gov
In Vivo Histology Evaluation of the CO2RE Device Versus the RePair Device in Pre- Abdominoplasty Patients
INTERVENTIONAL
Inicio: 1 de may de 2014
ID: NCT02147756
Completado
Fase 3
ClinicalTrials.gov
Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™
INTERVENTIONAL
Inicio: 1 de dic de 2001
ID: NCT00600327
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effects of EDP-938 in Hematopoietic Cell Transplant Recipients With Acute Respiratory Syncytial Virus Infection of the Upper Respiratory Tract
INTERVENTIONAL
Inicio: 7 de jul de 2021
ID: NCT04633187
Completado
Fase 3
ClinicalTrials.gov
A Multi-centre, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects Who Participated in theMEA115588 or MEA115575 Trials
INTERVENTIONAL
Inicio: 27 de may de 2013
ID: NCT01842607
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Open-Label, Parallel-Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de ago de 2006
ID: NCT00356109
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-blind, Active-controlled, Parallel-group, Multi-center Study in Hemodialysis Participants With Anemia of Chronic Kidney Disease to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of Daprodustat Compared to Recombinant Human Erythropoietin, Following a Switch From Recombinant Human Erythropoietin or Its Analogs
INTERVENTIONAL
Inicio: 5 de sept de 2018
ID: NCT03400033
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction (PARAGON-HF)
INTERVENTIONAL
Inicio: 18 de jul de 2014
ID: NCT01920711
Terminado
Fase 3
ClinicalTrials.gov
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
INTERVENTIONAL
Inicio: 1 de dic de 2010
ID: NCT01127633
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3b, Multicenter, Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
INTERVENTIONAL
Inicio: 28 de feb de 2025
ID: NCT06855498
Completado
Fase 3
ClinicalTrials.gov
Effect of LY2062430, an Anti-Amyloid Beta Monoclonal Antibody, on the Progression of Alzheimer's Disease as Compared With Placebo
INTERVENTIONAL
Inicio: 1 de may de 2009
ID: NCT00905372
Terminado
Fase 2
ClinicalTrials.gov
A 52-Week, Two-Period, Multicenter, Randomized, Double-Blind, Donepezil-Referenced, Placebo-Controlled, Efficacy And Safety Study Of 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease
INTERVENTIONAL
Inicio: 1 de may de 2009
ID: NCT00895895
Completado
Fase 3
ClinicalTrials.gov
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures in a Double-blind, Randomised, Placebo-controlled, Parallel-group, Multicentre Trial
INTERVENTIONAL
Inicio: 2 de dic de 2008
ID: NCT00988429
Completado
Fase 3
ClinicalTrials.gov
A Multinational, Randomized, Double-blind, Placebo-controlled, Forced-titration, 2 x 2 Factorial Design Study of the Efficacy and Safety of Long-term Administration of Nateglinide and Valsartan in the Prevention of Diabetes and Cardiovascular Outcomes in Subjects With Impaired Glucose Tolerance (IGT)
INTERVENTIONAL
Inicio: 1 de ene de 2002
ID: NCT00097786
Reclutando
ClinicalTrials.gov
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
OBSERVATIONAL
Inicio: 1 de jul de 2012
ID: NCT01574053
Completado
ClinicalTrials.gov
A Multicenter, Global, Retrospective, Observational Study to Characterize Real-world Clinical Outcomes in Patients With Relapsing-remitting Multiple Sclerosis Treated With Disease-modifying Therapies (Tecfidera®, Copaxone®, Aubagio®, or Gilenya®)
OBSERVATIONAL
Inicio: 1 de may de 2016
ID: NCT02776072
Terminado
Fase 3
ClinicalTrials.gov
An Open-Label, Single-Arm Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Early Stage Relapsing Remitting Multiple Sclerosis
INTERVENTIONAL
Inicio: 24 de mar de 2017
ID: NCT03085810
Completado
Fase 3
ClinicalTrials.gov
A Multicenter Study to Evaluate Long-term Safety and Tolerability of Open Label Sacubitril/Valsartan in Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed Study CLCZ696B2319
INTERVENTIONAL
Inicio: 2 de may de 2019
ID: NCT03785405
Anterior
1
...
31
32
33
...
434
Siguiente
Filtros